Covance to Present at Goldman Sachs Thirtieth Annual Global Healthcare Conference
PRINCETON, N.J., June 10 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today announced that it will present at Goldman Sachs Thirtieth Annual Global Healthcare Conference on Thursday, June 11, 2009 at 10:20 a.m. (ET). Investors may access a live webcast of the presentation at www.covanc...Amgen to Present at the Goldman Sachs Global Healthcare Conference
THOUSAND OAKS, Calif., June 8 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) will present at the Goldman Sachs Global Healthcare Conference on Wednesday, June 10, 2009 at the Grand Hyatt, New York City, N.Y., beginning at 9:00 a.m. Eastern Time. Roger M. Perlmutter, Amgen's Executive Vice Pres...Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference
ARDEE, Ireland, June 8 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX ) announced today that it will present at the Goldman Sachs 30th Annual Healthcare Conference on Wednesday, June 10, 2009 at 10:20 a.m. ET. Presenting for Warner Chilcott will be Roger Boissonneault, Presiden...Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
CHADDS FORD, Pa., June 5 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it will present at the Goldman Sachs 30th Annual Healthcare Conference on Wednesday, June 10, 2009 at 4:30 pm Eastern Time. Dave Holveck, President and Chief Executive Officer of Endo, w...Abbott to Present at Goldman Sachs Global Healthcare Conference
ABBOTT PARK, Ill., June 1 /PRNewswire-FirstCall/ -- Abbott will present at the Goldman Sachs 30th Annual Global Healthcare Conference on Wednesday, June 10, 2009. Miles D. White, chairman and chief executive officer, and Thomas C. Freyman, executive vice president, finance and chief financial offi...Beckman Coulter to Present at the 2009 Goldman Sachs Healthcare Conference
ORANGE COUNTY, Calif., May 29 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Allan Harris, Beckman Coulter's vice president of strateg...Air Products' CEO to Address Goldman Sachs Basic Materials Conference on 4 June
LEHIGH VALLEY, Pa., May 28 /PRNewswire-FirstCall/ -- Air Products (NYSE: APD ) announced today that Chairman, President and Chief Executive Officer John E. McGlade will be presenting at the Goldman Sachs Basic Materials Conference in New York on Thursday, June 4, 2009, at 8:00 a.m. EDT. An...Hill-Rom to Participate in the Goldman Sachs 30th Annual Global Healthcare Conference
BATESVILLE, Ind., May 26 /PRNewswire-FirstCall/ -- Hill-Rom Holdings, Inc., (NYSE: HRC ) invites you to listen to a discussion with Peter H. Soderberg, president and chief executive officer, Hill-Rom. He will be participating in the Goldman Sachs 30th Annual Healthcare Conference in New York Ci...Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
PRINCETON, N.J., June 2 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announces management will present at the Goldman Sachs Global Healthcare Conference and the Needham Healthcare Conference. Both conferences will be held in New York, NY. Schaefer Price, Pharmasset's President...Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
...mpany is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman sachs and Invesco Perpetual. For more information please visit http://www.circassia.co.uk. Contacts: Steve Harris Rob Budge CEO RJB...Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
...mpany is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman sachs and Invesco Perpetual. For more information please visit http://www.circassia.co.uk. Contacts Steve Harris Rob Budge...Texas Back Institute Leads Way in New Facet Joint Clinical Trial
...inical trial of the Total Facet Arthroplasty System (TFAS)(R). Dr. Barton sachs of Texas Back Institute performed the TFAS procedure on Ron Kaipus in Septe...uture of the trial." There are openings within the clinical trial and Dr. sachs explained that patients affected with spinal stenosis or spondylolisthesis ...Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
...ounds is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman sachs and Invesco Perpetual. Circassia's lead products target allergies utilizing the company's proprietary T-cell epitope desensitization technology, Tol...Study Sheds Light on Medication Treatment Options for Bipolar Disorder
... adjusted participants mood stabilizer doses to optimal levels, ensuring that they were receiving the most appropriate amount. After about 26 weeks, sachs and colleagues found that 24 percent of those who had been randomized to the antidepressants stayed well for at least eight consecutive weeks — ...Stanford launches $100 million initiative to tackle energy issues
...nded Farallon in 1986. He is also managing director of Hellman & Friedman, a San Francisco-based private equity firm. He previously worked for Goldman sachs and Morgan Stanley & Co. He is a graduate of the Stanford Graduate School of Business. Taylor earned a joint JD/MBA degree from the Stanford Law Schoo...bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
...eywell International, Inc., ASSA ABLOY Door Security Solutions, Diebold, Inc., BOSCH, NetApp, SimplexGrinnel LLC, General Electric Company and Goldman sachs & Company. Frank's experience involved working with those clients to recognize critical security issues, architecting and designing comprehensive solu...Study of guanacos launched in Chile
...iversity of the area.. Donated to WCS by Goldman sachs in 2004, Karukinka consists of 740,000 acres of wi...ogs, unique river systems, and grasslands. Goldman sachs has provided key funding for this guanaco study. ...ndering over large landscapes. We commend Goldman sachs for their support to help protect an iconic specie...Now is Africa's turn for a green revolution, global experts say
...about U.S. food aid policy as shipping food is more expensive than raising crops locally. In his talk, The Economics of the African Green Revolution, sachs will draw on his work to end world poverty and hunger in discussing effective strategies for progress in Africa. Currently, he is special advisor to U...UD hosts conference on knowledge-based partnerships Nov. 2
... Chad Holliday, chairman and chief executive officer of DuPont, and Abby Joseph Cohen, partner and chief U.S. investment strategist with Goldman sachs & Co., will be featured speakers at a University of Delaware conference, Creating Knowledge-Based Partnerships: Challenges and Opportunities, to be he...Public Library of Science to launch new, open access journal on neglected tropical diseases
...y experts from developing countries, and some of the biggest names in tropical medicine and global health, including renowned health economist Jeffrey sachs and the director of the World Health Organization's African river blindness control program, Uche Amazigo. Dr. Amazigo said: "PLoS Neglected Tropi...UCLA scientists store materials in cells natural vaults
...s directly to a tumor cell without harming healthy tissue * Enzyme delivery to replace missing or defective enzymes, such as those that cause Tay sachs disease * DNA delivery to correct genetic mutations * Timed release of drugs, enzymes and DNA * Extracting and imprisoning cellular tox...Potential treatments for neurofibromatosis
...ently little can be done to treat a disease that affects more people than cystic fibrosis, hereditary muscular dystrophy, Huntington's disease and Tay sachs combined. Now, however, research by IU School of Medicine scientist D. Wade Clapp, M.D., and his colleagues David A. Ingram, Jr., M.D. and Feng-Chu...Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference
SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Goldman Sachs Annual Global Health Care Conference on Tuesday, June 9, 2009 at 10:45 a.m. ET / 7:45 a.m. PT in New York. Daniel M. Bradbury, president and chief executive officer...InterMune to Present at Goldman Sachs Healthcare Conference
BRISBANE, Calif., June 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that Daniel Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Goldman Sachs 30th Annual Global Healthcare Conference in New York on June 9, 2009 at 2:35 p.m. ...BioMarin to Present at the Goldman Sachs Healthcare Conference
NOVATO, Calif., June 2 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the Goldman Sachs 30th Annual Global Healthcare Conference in New York City on Tuesday, ...Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
MADISON, N.J., Jan. 5 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) announced today that it will present at the Goldman Sachs Healthcare CEOs Unscripted Conference on Wednesday, January 7, 2009 at 8:05 a.m. Eastern Time. Presenting for Wyeth will be Bernard Poussot, Chairman, President and Chief...BioMS Medical to present at Sachs Associates Biotech in Europe Forum
Toronto Stock Exchange Symbol: MS EDMONTON, Sept. 19 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Tony Hesby, Executive Vice President, Corporate Affairs, will present at the Sachs Associates ...Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
SAN DIEGO, June 5 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Goldman Sachs Global Healthcare Conference in Dana Point on Wednesday, June 11, 2008 at 1:20 p.m. PT. Daniel M. Bradbury, President and Chief Executive Officer of Amylin Pharmace...Boston Scientific to Participate in Goldman Sachs Conference
NATICK, Mass., June 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in Goldman Sachs' Annual Healthcare Conference, which is being held June 9-12 in Dana Point, CA. Jim Tobin, Boston Scientific Chief Executive Officer, will make a 10-minute...PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
BOSTON, June 5 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ) announced today it will be presenting at the Goldman Sachs 29th Annual Global Healthcare Conference at The Ritz Carlton - Laguna Niguel in Dana Point, California. James Winschel, Senior Vice President a...